Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

OLK

Olink Holding AB (OLK)

Olink Holding AB
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OLK
DataHoraFonteTítuloCódigoCompanhia
11/06/202411:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OLKOlink Holding AB
11/06/202410:00GlobeNewswire Inc.Notice to attend the Extra General Meeting of Olink Holding AB (publ)NASDAQ:OLKOlink Holding AB
06/06/202403:00GlobeNewswire Inc.Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute ConfidenceNASDAQ:OLKOlink Holding AB
30/05/202409:00GlobeNewswire Inc.Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before DiagnosisNASDAQ:OLKOlink Holding AB
13/05/202407:00GlobeNewswire Inc.Olink reports first quarter 2024 financial resultsNASDAQ:OLKOlink Holding AB
19/04/202417:05GlobeNewswire Inc.Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024NASDAQ:OLKOlink Holding AB
02/04/202409:00GlobeNewswire Inc.Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of DiseaseNASDAQ:OLKOlink Holding AB
25/03/202409:00GlobeNewswire Inc.Olink reports fourth quarter and full year 2023 financial resultsNASDAQ:OLKOlink Holding AB
25/03/202409:00GlobeNewswire Inc.Olink publishes 2023 annual reportNASDAQ:OLKOlink Holding AB
15/03/202409:00GlobeNewswire Inc.Notice to attend the Annual General Meeting of Olink Holding AB (publ)NASDAQ:OLKOlink Holding AB
08/03/202410:00GlobeNewswire Inc.Olink announces change of date for Annual General MeetingNASDAQ:OLKOlink Holding AB
01/03/202418:45Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:OLKOlink Holding AB
15/11/202309:00GlobeNewswire Inc.Olink reports third quarter 2023 financial resultsNASDAQ:OLKOlink Holding AB
05/11/202322:00GlobeNewswire Inc.Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomicsNASDAQ:OLKOlink Holding AB
31/10/202312:36Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:OLKOlink Holding AB
17/10/202319:40Business WireThermo Fisher Scientific prépare l'acquisition d'Olink, leader de la protéomique de nouvelle générationNASDAQ:OLKOlink Holding AB
17/10/202319:39Business WireThermo Fisher Scientific übernimmt Olink, ein führendes Unternehmen der Proteomik der nächsten GenerationNASDAQ:OLKOlink Holding AB
17/10/202318:28Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:OLKOlink Holding AB
17/10/202311:16Dow Jones NewsOlink Holding Shares Soar on Takeover by Thermo FisherNASDAQ:OLKOlink Holding AB
17/10/202310:01Dow Jones NewsThermo Fisher to Buy Olink in $3.1 Billion DealNASDAQ:OLKOlink Holding AB
17/10/202309:19Business WireThermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation ProteomicsNASDAQ:OLKOlink Holding AB
05/10/202317:25GlobeNewswire Inc.Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomicsNASDAQ:OLKOlink Holding AB
19/09/202304:00GlobeNewswire Inc.Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.NASDAQ:OLKOlink Holding AB
12/09/202312:00GlobeNewswire Inc.Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programsNASDAQ:OLKOlink Holding AB
29/08/202309:00GlobeNewswire Inc.Olink to participate in September investor eventsNASDAQ:OLKOlink Holding AB
17/08/202321:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OLKOlink Holding AB
09/08/202308:00GlobeNewswire Inc.Olink reports second quarter 2023 financial resultsNASDAQ:OLKOlink Holding AB
08/08/202309:00GlobeNewswire Inc.Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platformNASDAQ:OLKOlink Holding AB
13/07/202309:00GlobeNewswire Inc.Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:OLKOlink Holding AB
12/07/202310:00GlobeNewswire Inc.Announcing Olink® Explore HT – A New Era in ProteomicsNASDAQ:OLKOlink Holding AB
 Apresentando as notícias mais relevantes sobre:NASDAQ:OLK